Sean N. Tucker
2021
In 2021, Sean N. Tucker earned a total compensation of $1.2M as Chief Scientific Officer at Biota Pharmaceuticals, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $123,159 |
|---|---|
| Option Awards | $694,380 |
| Salary | $362,232 |
| Other | $9,379 |
| Total | $1,189,150 |
Tucker received $694.4K in option awards, accounting for 58% of the total pay in 2021.
Tucker also received $123.2K in non-equity incentive plan, $362.2K in salary and $9.4K in other compensation.
Rankings
In 2021, Sean N. Tucker's compensation ranked 8,154th out of 12,405 executives tracked by ExecPay. In other words, Tucker earned more than 34.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,154 out of 12,405 | 34th |
Division Manufacturing | 3,606 out of 5,494 | 34th |
Major group Chemicals And Allied Products | 1,603 out of 2,369 | 32nd |
Industry group Drugs | 1,425 out of 2,090 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 318 out of 452 | 30th |
Source: SEC filing on April 28, 2023.
Tucker's colleagues
We found two more compensation records of executives who worked with Sean N. Tucker at Biota Pharmaceuticals in 2021.
News
Biota Pharmaceuticals CEO Andrei Floroiu's 2023 pay falls 48% to $1.9M
April 29, 2024
Biota Pharmaceuticals CEO Andrei Floroiu's 2022 pay jumps 49% to $3.6M
April 28, 2023
Biota Pharmaceuticals CEO Wouter Latour's 2020 pay jumps 280% to $2.8M
April 30, 2021
Biota Pharmaceuticals CEO Wouter Latour's 2019 pay slips 12% to $748K
April 24, 2020
Biota Pharmaceuticals CEO Joseph Patti's 2018 pay rises 12% to $1.2M
March 11, 2019